‘An increased ability to be disease-free’: Moderna CEO & Merck’s Dr. Li on skin cancer vaccine trial

Stephane Bancel, Moderna CEO, and Dr. Dean Li, Merck Research Laboratories president, join 'Squawk Box' to discuss details of an experimental personalized cancer vaccine that showed positive initial results in its first-ever late-stage trial, how themRNA-based shotin combination with Merck’s immunotherapy Keytruda could serve as a new treatment option for melanoma, and more.

CNBC Television

https://youtu.be/HT6ukBZe10w